Literature DB >> 7679706

Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.

T W De Graaf1, M E Van der Stelt, M G Anbergen, W van Dijk.   

Abstract

The glycosylation of the acute phase glycoprotein alpha 1-acid glycoprotein (AGP) in human sera is subject to marked changes during acute inflammation as a result of the cytokine-induced hepatic acute phase reaction. The changes described thus far comprise alterations in the type of branching of the carbohydrate structures as revealed by increased reactivity of AGP with concanavalin A. We now report on acute inflammation-induced increases in alpha 1-->3-fucosylated AGP molecules, as detected by the reactivity of AGP towards the fucose-binding Aleuria aurantia lectin (AAL) in crossed affino-immunoelectrophoresis of human sera. Laparotomy of women, for the removal of benign tumors of the uterus, was used as a model for the development of the hepatic acute phase response. Hugh increases were detected in the amounts of strongly AAL-reactive fractions of AGP, presumably containing three or more fucosylated N-acetyllactosamine units. At least part of these Lewis X-type glycans (Gal beta 1-->[Fuc alpha 1-->3]GlcNAc-R) appeared to be substituted also with an alpha 2-->3-linked sialic acid residue. This was revealed by the laparotomy-induced abundant staining of AGP with an antisialyl Lewis X monoclonal antibody (CSLEX-1) on blots of sodium dodecyl sulfate-polyacrylamide gels containing AGP isolated from the sera of a patient at various days after operation. It is concluded that acute inflammation induces a strong increase in sialyl Lewis X-substituted AGP molecules that persists at a high level throughout the inflammatory period. We postulate that these changes represent a physiological feedback response on the interaction between leukocytes and inflamed endothelium, which is mediated via sialylated Lewis X structures and the selectin endothelial-leukocyte adhesion molecule 1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679706      PMCID: PMC2190949          DOI: 10.1084/jem.177.3.657

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

Review 1.  Human alpha 1-3 fucosyltransferases.

Authors:  B A Macher; E H Holmes; S J Swiedler; C L Stults; C A Srnka
Journal:  Glycobiology       Date:  1991-12       Impact factor: 4.313

2.  Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography.

Authors:  T C Bog-Hansen
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

3.  Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein.

Authors:  M Costello; B A Fiedel; H Gewurz
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

4.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

5.  Structures of the oligosaccharide chains of two forms of alpha 1-acid glycoprotein purified from liver metastases of lung, colon, and breast tumors.

Authors:  E V Chandrasekaran; M Davila; D Nixon; J Mendicino
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

6.  Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4GlcNAc alpha 2 leads to 6 sialyltransferase from liver.

Authors:  H A Kaplan; B M Woloski; M Hellman; J C Jamieson
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

7.  Changes in the blood level and affinity to concanavalin A of rat plasma glycoproteins during acute inflammation and hepatoma growth.

Authors:  A Koj; A Dubin; H Kasperczyk; J Bereta; A H Gordon
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

8.  Structure of the major oligosaccharides in the fusion glycoprotein of Newcastle disease virus.

Authors:  S Diabaté; R Geyer; S Stirm
Journal:  Eur J Biochem       Date:  1984-03-01

9.  Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety.

Authors:  M Bennett; K Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Evidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man.

Authors:  I Nicollet; J P Lebreton; M Fontaine; M Hiron
Journal:  Biochim Biophys Acta       Date:  1981-04-28
View more
  58 in total

1.  Sialyl Lewis(x) expression on IgG in rheumatoid arthritis and other arthritic conditions: a preliminary study.

Authors:  M T Goodarzi; J S Axford; S S Varanasi; A Alavi; G Cunnane; O Fitzgerald; G A Turner
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

2.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

3.  Glycosylation and over-expression of endometriosis-associated peritoneal haptoglobin.

Authors:  Marta Piva; J Ignacio Moreno; Kathy L Sharpe-Timms
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

Review 4.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

5.  Immunological evaluation of urinary trypsin inhibitors in blood and urine: role of N- & O-linked glycoproteins.

Authors:  Michael J Pugia; Saeed A Jortani; Manju Basu; Ronald Sommer; Hai-Hang Kuo; Solomon Murphy; Doug Williamson; James Vranish; Patrick J Boyle; Danny Budzinski; Roland Valdes; Subhash C Basu
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

Review 6.  C1 inhibitor: biologic activities that are independent of protease inhibition.

Authors:  Alvin E Davis; Shenghe Cai; Dongxu Liu
Journal:  Immunobiology       Date:  2006-12-11       Impact factor: 3.144

7.  Studies on the interaction between hyaluronan and a rat colon cancer cell line.

Authors:  C Samuelsson; S Gustafson
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

Review 8.  The importance of oligosaccharides to rheumatic disease: a personal perspective.

Authors:  J S Axford
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

Review 9.  The lipocalin protein family: structure and function.

Authors:  D R Flower
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

10.  The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery.

Authors:  Scott R Kronewitter; Maria Lorna A De Leoz; John S Strum; Hyun Joo An; Lauren M Dimapasoc; Andrés Guerrero; Suzanne Miyamoto; Carlito B Lebrilla; Gary S Leiserowitz
Journal:  Proteomics       Date:  2012-08       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.